Clinical Trial Update: ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ARQ 197 in combination with chemotherapy in metastatic colorectal cancer; phases 1 and 2 completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ARQ 197 (tivantinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-14